Form 4 for BMY Bristol Myers Squibb
Accepted 2023-08-07 00:00:00 ET · period of report 2023-08-03 · accession 0000014272-23-000154 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-08-07 | 2023-08-03 | BMY | Plenge Robert M | EVP, Chief Research Off | S - Sale | $61.14 | -732 | 6,584 | -10% | -$44.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, $0.10 par value | 2023-08-03 | S | D | 732 | $61.14 | 6,584 | D | — | — | (F1) The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $61.142 to $61.145, inclusive. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. |